In convalescent samples and samples 28 days post vaccine dose 2, the majority (75%) of HLA-A*02:01-ILD tetramer-positive CD8+ T cells were CD45RA+CCR7− effector cells, with minimal levels of CD45RA+CCR7+ naïve cells (Fig. 4E). The gene discussed is CCR7; the disease is interstitial lung disease.